Analytical Data
-
Gene name
Zhi
- Application
-
Alternative Names
(LZ-8)
-
Species
Ganoderma lucidum
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P14945
-
Expression Region
2-111aa
-
Molecular Weight
19.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of Zhi recombinant proteins has gained significant attention in the field of molecular biology and biotechnology due to their potential applications in various areas, including medicine, agriculture, and industrial processes. Zhi, or "Zhi protein," refers to specific proteins that undergo recombinant DNA technology to produce desired characteristics not found in nature. Researchers are focused on the expression and purification of these proteins, which are often used for therapeutic purposes, such as in vaccine development or enzyme replacement therapies. The ability to produce these proteins in large quantities and with high purity has opened up new avenues for drug development and research into disease mechanisms. Moreover, recombinant proteins derived from Zhi can be engineered to possess enhanced stability, activity, or specificity, making them valuable tools in diagnostic assays or as therapeutic agents. The demand for innovative treatments for various diseases further propels the research in this area, leading scientists to explore different expression systems and optimization strategies. Understanding the structure-function relationships of these proteins is also crucial, as it provides insights into their biological roles and interactions. Overall, the research on Zhi recombinant proteins represents a promising frontier in biomedicine, offering the potential to address complex challenges in health and disease management.
